Published in J Biol Chem on October 19, 2012
Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell (2013) 8.37
Modification of enhancer chromatin: what, how, and why? Mol Cell (2013) 3.62
Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov (2014) 3.54
Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell (2013) 3.13
The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Mol Cell (2014) 2.47
BET bromodomains mediate transcriptional pause release in heart failure. Cell (2013) 2.17
BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin. Nat Struct Mol Biol (2016) 2.15
The selection and function of cell type-specific enhancers. Nat Rev Mol Cell Biol (2015) 1.93
Regulation of MYC expression and differential JQ1 sensitivity in cancer cells. PLoS One (2014) 1.57
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia. Mol Cell (2015) 1.36
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. Proc Natl Acad Sci U S A (2013) 1.35
The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. Cell Rep (2013) 1.26
BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nat Struct Mol Biol (2014) 1.25
Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription. Cell Rep (2014) 1.19
Enhancers are major targets for murine leukemia virus vector integration. J Virol (2014) 1.10
The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation. Proc Natl Acad Sci U S A (2015) 1.05
Protein lysine acetylation by p300/CBP. Chem Rev (2015) 1.02
Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1. J Biol Chem (2014) 1.01
Selective chemical modulation of gene transcription favors oligodendrocyte lineage progression. Chem Biol (2014) 1.01
Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells. PLoS One (2014) 1.01
Molecular mechanisms of retroviral integration site selection. Nucleic Acids Res (2014) 1.01
Epigenetic Readers of Lysine Acetylation Regulate Cocaine-Induced Plasticity. J Neurosci (2015) 0.96
BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements. Mol Ther Nucleic Acids (2014) 0.91
Bromodomain inhibitors regulate the C9ORF72 locus in ALS. Exp Neurol (2015) 0.91
The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis. Front Oncol (2015) 0.89
Dynamic enhancer-gene body contacts during transcription elongation. Genes Dev (2015) 0.89
BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction. J Dent Res (2014) 0.88
Histone cross-talk connects protein phosphatase 1α (PP1α) and histone deacetylase (HDAC) pathways to regulate the functional transition of bromodomain-containing 4 (BRD4) for inducible gene expression. J Biol Chem (2014) 0.88
The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response. Cell Death Dis (2014) 0.83
Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma. Epigenetics (2015) 0.83
Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers. Breast Cancer Res Treat (2013) 0.82
Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement. Breast Cancer Res Treat (2015) 0.82
Epigenetic targets for novel therapies of lung diseases. Pharmacol Ther (2014) 0.81
H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription. Oncotarget (2015) 0.80
Genome-wide Profiling Reveals Remarkable Parallels Between Insertion Site Selection Properties of the MLV Retrovirus and the piggyBac Transposon in Primary Human CD4(+) T Cells. Mol Ther (2016) 0.80
Enhancer alterations in cancer: a source for a cell identity crisis. Genome Med (2014) 0.80
GC skew defines distinct RNA polymerase pause sites in CpG island promoters. Genome Res (2015) 0.79
BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire. Nucleic Acids Res (2016) 0.79
The BET protein FSH functionally interacts with ASH1 to orchestrate global gene activity in Drosophila. Genome Biol (2013) 0.79
Differences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice. In Vivo (2014) 0.78
Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors. Leukemia (2016) 0.77
The bromodomain protein BRD4 regulates splicing during heat shock. Nucleic Acids Res (2016) 0.77
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies. Oncotarget (2016) 0.77
Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension. Respirology (2016) 0.77
T-bet Activates Th1 Genes through Mediator and the Super Elongation Complex. Cell Rep (2016) 0.76
Bromodomain 4: a cellular Swiss army knife. J Leukoc Biol (2016) 0.76
Bromodomain and Extra-terminal Proteins (BET) Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth. J Biol Chem (2016) 0.76
Erythropoiesis provides a BRD's eye view of BET protein function. Drug Discov Today Technol (2016) 0.76
An Epigenetic Compound Library Screen Identifies BET Inhibitors That Promote HSV-1 and -2 Replication by Bridging P-TEFb to Viral Gene Promoters through BRD4. PLoS Pathog (2016) 0.76
Chromatin architecture underpinning transcription elongation. Nucleus (2016) 0.75
Chromatin Landscape of the IRF Genes and Role of the Epigenetic Reader BRD4. J Interferon Cytokine Res (2016) 0.75
Genome-wide redistribution of BRD4 binding sites in transformation resistant cells. Genom Data (2015) 0.75
Epigenetic drug discovery: breaking through the immune barrier. Nat Rev Drug Discov (2016) 0.75
Bromodomain and Extra-Terminal Protein Inhibition Attenuates Neutrophil-dominant Allergic Airway Disease. Sci Rep (2017) 0.75
High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML. Cell Rep (2016) 0.75
Hotspots of MLV integration in the hematopoietic tumor genome. Oncogene (2016) 0.75
Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation. Mol Cell (2017) 0.75
BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice. Proc Natl Acad Sci U S A (2017) 0.75
Epigenome mapping highlights chromatin-mediated gene regulation in the protozoan parasite Trichomonas vaginalis. Sci Rep (2017) 0.75
BET proteins are a key component of immunoglobulin gene expression. Epigenomics (2017) 0.75
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes. Mol Cell (2017) 0.75
High-resolution profiling of histone methylations in the human genome. Cell (2007) 85.74
BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics (2010) 53.23
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (1996) 26.19
Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 24.41
A high-resolution map of active promoters in the human genome. Nature (2005) 24.35
Java Treeview--extensible visualization of microarray data. Bioinformatics (2004) 24.12
A chromatin landmark and transcription initiation at most promoters in human cells. Cell (2007) 23.41
Selective inhibition of BET bromodomains. Nature (2010) 18.79
Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet (2008) 18.28
Widespread transcription at neuronal activity-regulated enhancers. Nature (2010) 16.52
High-resolution mapping and characterization of open chromatin across the genome. Cell (2008) 15.93
Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A (2010) 15.13
BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell (2011) 14.34
A unique chromatin signature uncovers early developmental enhancers in humans. Nature (2010) 14.02
c-Myc regulates transcriptional pause release. Cell (2010) 11.64
A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A (2006) 10.63
The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell (2005) 8.95
Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell (2005) 8.92
Suppression of inflammation by a synthetic histone mimic. Nature (2010) 8.80
Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell (2009) 8.69
Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev (2005) 7.21
Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell (2007) 6.62
Control of inducible gene expression by signal-dependent transcriptional elongation. Cell (2009) 6.57
FindPeaks 3.1: a tool for identifying areas of enrichment from massively parallel short-read sequencing technology. Bioinformatics (2008) 6.53
The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci U S A (2003) 5.59
Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell (2005) 5.38
The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J Biol Chem (2007) 5.06
NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell (2001) 4.55
Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell (2009) 3.45
Diversified transcription initiation complexes expand promoter selectivity and tissue-specific gene expression. Genes Dev (2003) 2.73
Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell (2011) 2.53
Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol (2005) 2.44
H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J (2011) 2.38
Distinct mechanisms control RNA polymerase II recruitment to a tissue-specific locus control region and a downstream promoter. Mol Cell (2001) 2.32
The role of enhancers as centres for general transcription factor recruitment. Trends Biochem Sci (2005) 2.14
Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol Cell (2007) 2.05
A genomic analysis of RNA polymerase II modification and chromatin architecture related to 3' end RNA polyadenylation. Genome Res (2008) 2.01
Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad Sci U S A (2003) 1.99
BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A (2012) 1.93
Pol II and its associated epigenetic marks are present at Pol III-transcribed noncoding RNA genes. Nat Struct Mol Biol (2010) 1.93
Regulating histone acetyltransferases and deacetylases. EMBO Rep (2003) 1.76
Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression. J Biochem (2007) 1.72
Highly restricted localization of RNA polymerase II within a locus control region of a tissue-specific chromatin domain. Mol Cell Biol (2003) 1.66
Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods (2007) 45.04
ABySS: a parallel assembler for short read sequence data. Genome Res (2009) 43.20
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Selective inhibition of BET bromodomains. Nature (2010) 18.79
Assembling millions of short DNA sequences using SSAKE. Bioinformatics (2006) 18.71
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
Slider--maximum use of probability information for alignment of short sequence reads and SNP detection. Bioinformatics (2008) 14.04
ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med (2010) 13.07
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. N Engl J Med (2007) 12.24
Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature (2010) 9.81
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature (2011) 9.71
De novo assembly and analysis of RNA-seq data. Nat Methods (2010) 9.69
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res (2004) 9.18
De novo transcriptome assembly with ABySS. Bioinformatics (2009) 8.38
The genome sequence of taurine cattle: a window to ruminant biology and evolution. Science (2009) 8.23
Host-gut microbiota metabolic interactions. Science (2012) 7.73
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med (2013) 7.48
Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med (2011) 7.35
FindPeaks 3.1: a tool for identifying areas of enrichment from massively parallel short-read sequencing technology. Bioinformatics (2008) 6.53
Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A (2011) 6.16
Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol (2003) 5.87
The new paradigm of flow cell sequencing. Genome Res (2008) 5.81
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
Histone recognition and large-scale structural analysis of the human bromodomain family. Cell (2012) 5.15
Alternative expression analysis by RNA sequencing. Nat Methods (2010) 5.02
The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science (2005) 4.74
The genetic landscape of high-risk neuroblastoma. Nat Genet (2013) 4.71
Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet (2010) 4.65
The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse. Proc Natl Acad Sci U S A (2006) 4.18
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
Genome-wide relationship between histone H3 lysine 4 mono- and tri-methylation and transcription factor binding. Genome Res (2008) 4.11
Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing. Nucleic Acids Res (2008) 4.08
Protein production and purification. Nat Methods (2008) 3.97
Sequence biases in large scale gene expression profiling data. Nucleic Acids Res (2006) 3.83
ORegAnno: an open-access community-driven resource for regulatory annotation. Nucleic Acids Res (2007) 3.80
Linear motif atlas for phosphorylation-dependent signaling. Sci Signal (2008) 3.77
Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res (2009) 3.69
Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell (2009) 3.51
Small-molecule inhibition of BRDT for male contraception. Cell (2012) 3.50
Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a 'safety belt' binding mechanism for the spindle checkpoint. EMBO J (2002) 3.42
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest (2010) 3.41
Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet (2006) 3.29
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc Natl Acad Sci U S A (2007) 3.21
miR-214 targets ATF4 to inhibit bone formation. Nat Med (2012) 3.01
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach. BMC Genomics (2006) 2.98
Critical residues for structure and catalysis in short-chain dehydrogenases/reductases. J Biol Chem (2002) 2.95
High quality SNP calling using Illumina data at shallow coverage. Bioinformatics (2010) 2.82
Locating mammalian transcription factor binding sites: a survey of computational and experimental techniques. Genome Res (2006) 2.82
Systematic sequencing of cDNA clones using the transposon Tn5. Nucleic Acids Res (2002) 2.78
The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc Natl Acad Sci U S A (2006) 2.73
Development and application of a salmonid EST database and cDNA microarray: data mining and interspecific hybridization characteristics. Genome Res (2004) 2.72
Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis (2011) 2.69
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol (2010) 2.60
Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology (2003) 2.59
Bromodomains as therapeutic targets. Expert Rev Mol Med (2011) 2.52
Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell (2008) 2.46
Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature (2010) 2.46
Hive plots--rational approach to visualizing networks. Brief Bioinform (2011) 2.46
T-cell factor 3 regulates embryonic stem cell pluripotency and self-renewal by the transcriptional control of multiple lineage pathways. Stem Cells (2008) 2.43
A SAGE approach to discovery of genes involved in autophagic cell death. Curr Biol (2003) 2.40
MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells (2007) 2.40
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. EMBO J (2008) 2.36
A mouse atlas of gene expression: large-scale digital gene-expression profiles from precisely defined developing C57BL/6J mouse tissues and cells. Proc Natl Acad Sci U S A (2005) 2.35
Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase. J Med Chem (2005) 2.34
Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. Structure (2009) 2.33
The (un)targeted cancer kinome. Nat Chem Biol (2010) 2.33
Transcriptome analysis of zebrafish embryogenesis using microarrays. PLoS Genet (2005) 2.32
HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A (2006) 2.30
Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell (2008) 2.28
An efficient strategy for large-scale high-throughput transposon-mediated sequencing of cDNA clones. Nucleic Acids Res (2002) 2.27
Assessment and integration of publicly available SAGE, cDNA microarray, and oligonucleotide microarray expression data for global coexpression analyses. Genomics (2005) 2.27
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. J Pathol (2011) 2.27
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function. Nat Chem Biol (2010) 2.26
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med (2011) 2.25
Structure of the CaMKIIdelta/calmodulin complex reveals the molecular mechanism of CaMKII kinase activation. PLoS Biol (2010) 2.22
The completion of the Mammalian Gene Collection (MGC). Genome Res (2009) 2.21
Assembling the 20 Gb white spruce (Picea glauca) genome from whole-genome shotgun sequencing data. Bioinformatics (2013) 2.18
Activation segment dimerization: a mechanism for kinase autophosphorylation of non-consensus sites. EMBO J (2008) 2.12
Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol (2006) 2.11
MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol Cell Biol (2009) 2.08
Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chem Biol (2011) 2.06
Sequencing the genome of the Atlantic salmon (Salmo salar). Genome Biol (2010) 2.06
Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol Cell (2007) 2.05
A physical map of the genome of Atlantic salmon, Salmo salar. Genomics (2005) 2.03
Artificial selection for determinate growth habit in soybean. Proc Natl Acad Sci U S A (2010) 2.02
The ELT-2 GATA-factor and the global regulation of transcription in the C. elegans intestine. Dev Biol (2006) 2.00
Structure and substrate specificity of the Pim-1 kinase. J Biol Chem (2005) 1.96
Analysis of long-lived C. elegans daf-2 mutants using serial analysis of gene expression. Genome Res (2005) 1.93
Specificity profiling of Pak kinases allows identification of novel phosphorylation sites. J Biol Chem (2007) 1.92
The bromodomain interaction module. FEBS Lett (2012) 1.92
Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver. Genome Res (2010) 1.90